No Data
Apeloa PharmaceuticalLtd's (SZSE:000739) Shareholders Have More To Worry About Than Only Soft Earnings
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Apeloa Pharmaceutical Co.,Ltd Just Missed EPS By 9.7%: Here's What Analysts Think Will Happen Next
Express News | Apeloa Pharmaceutical Says 2024 Net Profit Down 2.3% Y/Y at 1.03 Bln Yuan
Prologis Pharmaceuticals: 2024 Annual Report
Prologis Pharmaceuticals: 2024 Annual Report Summary
Is Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
